Unifiram (DM-232)
Experimental Nootropic
Unifiram is an experimental pyrrolidinone-derived compound studied in rodent learning models. Its enantiomers differ in preclinical potency, and vendor material has no established clinical identity, dose, or safety.
Pharmacokinetic model
A route-level PK model for unifiram (dm-232) is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Experimental Nootropic
- Suggested cadence
- once daily
Research behind this entry
-
Enantioselective synthesis and preliminary pharmacological evaluation of the enantiomers of unifiram (DM232), a potent cognition-enhancing agent
Unifiram enantiomers were synthesized and tested in mouse behavioral assays and rat-cortex acetylcholine-release experiments. The R enantiomer was more potent in those preclinical tests; no humans, pharmacokinetics,…
1 published study referenced in the app, each with a plain-language summary.